Casi pharmaceuticals announces market approval of cnct19 by china nmpa

Beijing , nov. 8, 2023 /prnewswire/ -- casi pharmaceuticals inc. (nasdaq: casi), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, is thrilled to announce a major milestone in its partnership with juventas cell therapy ltd. (juventas).
CASI Ratings Summary
CASI Quant Ranking